In this review, we tried to evaluate the current evidence about modified ultrafiltration (MUF) on the organ performance and its effect on post-cardiopulmonary bypass (CPB) morbidity in pediatric patients.
Current best evidence indicates that tranexamic acid may reduce both the duration and volume of bleeding, with low risk of short-term thromboembolic complications, in patients with haemoptysis.
